Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3)

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca
 

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3)

EDITORIAL  HIGH-GRADE GLIOMA

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):221-4

Neuroimaging in patients with high-grade gliomas

Norbert GALLDIKS *

HTML PDF

REVIEW  HIGH-GRADE GLIOMA

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):225-38

Overview on current treatment standards in high-grade gliomas

Alessia PELLERINO *, Federica FRANCHINO, Riccardo SOFFIETTI, Roberta RUDÀ

Abstract HTML PDF

REVIEW  HIGH-GRADE GLIOMA

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):239-53

Conventional and advanced magnetic resonance imaging in patients with high-grade glioma

Whitney B. POPE *, Garth BRANDAL

Abstract HTML PDF

REVIEW  HIGH-GRADE GLIOMA

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):254-66

Role of amino-acid PET in high-grade gliomas: limitations and perspectives

Antoine VERGER *, Javier ARBIZU, Ian LAW

Abstract HTML PDF

REVIEW  HIGH-GRADE GLIOMA

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):267-71

The role of amino-acid PET in the light of the new WHO classification 2016 for brain tumors

Bogdana SUCHORSKA *, Nathalie L. ALBERT, Elena K. BAUER, Jörg-Christian TONN, Norbert GALLDIKS

Abstract HTML PDF

REVIEW  HIGH-GRADE GLIOMA

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):272-80

Radiomics derived from amino-acid PET and conventional MRI in patients with high-grade gliomas

Philipp LOHMANN *, Martin KOCHER, Jan STEGER, Norbert GALLDIKS

Abstract HTML PDF

REVIEW  HIGH-GRADE GLIOMA

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):281-94

Investigational PET tracers for high-grade gliomas

Gagandeep CHOUDHARY, Karl-Josef LANGEN, Norbert GALLDIKS, Jonathan McCONATHY *

Abstract HTML PDF

REVIEW  HIGH-GRADE GLIOMA

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):295-302

Functional magnetic resonance imaging in glioma patients: from clinical applications to future perspectives

Lukas J. VOLZ *, Martin KOCHER, Philipp LOHMANN, Nadim J. SHAH, Gereon R. FINK, Norbert GALLDIKS

Abstract HTML PDF

ORIGINAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):303-12

Half-time bone scintigraphy in prostate and breast cancer patients

Willem GROOTJANS *, Sara J. SERÉM, Monique I. GOMES, Linda HEIJMEN, Ben F. BULTEN, Eddy P. MIJNHEERE, Rick HERMSEN, Wim J. van den BROEK

Abstract PDF

ORIGINAL ARTICLE  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):313-20

Evaluation of predictor variables of diagnostic [18F] FDG-PET/CT in fever of unknown origin

Kursat OKUYUCU, Engin ALAGOZ, Seref DEMİRBAS, Semra INCE *, Ahmet KARAKAS, Ozgur KARACALİOGLU, Bengul GUNALP, Nuri ARSLAN

Abstract PDF

REVIEW  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):321-4

Clinical value of quantitative measurements derived from GATED SPECT: motion and thickening, volumes and related LVEF

Walter NOORDZIJ *, Riemer H. SLART

Abstract PDF

REVIEW  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):325-35

Reversible myocardial perfusion defects in patients not suffering from obstructive epicardial coronary artery disease as assessed by coronary angiography

Christophe van de WIELE *, Adriana RIMBU, Tarik BELHOCINE, Bart de SPIEGELEER, Mike SATHEKGE, Alex MAES

Abstract PDF

inizio pagina